GILD.TSX
Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC

0
52W High
$26.29
Volume
80.00
52W Low
$20.08
Price
$26.08
Prev Close
$25.39
GILD.TSX Fundamentals
Open
$26.08
50D MA
$25.25
Beta
0.58
Avg. Volume
5,470.00
Loading...
Loading...
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC?
What is the 52-week low for Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC?
What is Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC stock price today?
What was Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC stock price yesterday?
What is the 50-day moving average of Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC?

Latest GILD.TSX News

View
No GILD.TSX news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.